-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
GMP productielicentie voor NecstGen
- Intro: December 2022. Een grote mijlpaal voor de Pilotfabriek. Eén van de pilotlijnen, NecstGen, heeft een GMP-productielicentie ontvangen. De licentie stelt NecstGen in staat om cel- en gentherapieën voor patiënten te produceren en vrij te geven.
Smart Biomaterials Consortium is on a roll!
On November 3rd 2022, exactly one year after the first meeting of the founders, the stakeholders of Smart Biomaterials Consortium gathered for the official start of the new shared development lab in Brainport Eindhoven.
read more
Geweldig! DON haalt ruim 1,7 miljoen op voor genezing diabetes type 1
Het was een fantastische avond: het lustrumgala van stichting DON op vrijdag 16 september 2022. Er werd die avond een recordbedrag van 1,7 miljoen opgehaald voor de genezing van diabetes type 1.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
